| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.759 | 0.002 | 0.759 | Nav1.1 sodium channel blocker | 0.69 0.003 DBMET00988 0.555 0.003 DBMET00990 0.606 0.003 DBMET00989 0.641 0.003 DBMET00992 0.468 0.004 DBMET00991 | ||
| 0.732 | 0.005 | 0.732 | Anticonvulsant | 0.332 0.032 DBMET00988 0.422 0.019 DBMET00990 0.495 0.012 DBMET00989 0.566 0.009 DBMET00992 0.286 0.044 DBMET00991 | ||
| 0.598 | 0.003 | 0.598 | Aldose reductase inhibitor | 0.367 0.004 DBMET00988 0.397 0.004 DBMET00990 0.527 0.003 DBMET00989 0.512 0.003 DBMET00992 0.494 0.003 DBMET00991 | ||
| 0.534 | 0.006 | 0.6 | Anesthetic general | 0.356 0.023 DBMET00988 0.551 0.005 DBMET00990 0.273 0.041 DBMET00888 0.537 0.006 DBMET00989 0.469 0.01 DBMET00992 0.6 0.004 DBMET00991 | DBMET00991 | |
| 0.536 | 0.028 | 0.698 | Aldehyde oxidase inhibitor | 0.253 0.081 DBMET00988 0.417 0.044 DBMET00990 0.452 0.04 DBMET00888 0.698 0.008 DBMET00989 0.565 0.024 DBMET00992 0.665 0.011 DBMET00991 | DBMET00989 | |
| 0.483 | 0.031 | 0.508 | GABA C receptor rho-3 antagonist | 0.265 0.142 DBMET00988 0.26 0.145 DBMET00990 0.508 0.024 DBMET00888 0.424 0.051 DBMET00989 0.435 0.047 DBMET00992 0.24 0.163 DBMET00991 | DBMET00888 | |
| 0.433 | 0.005 | 0.448 | Tumour necrosis factor antagonist | 0.268 0.025 DBMET00988 0.362 0.009 DBMET00990 0.145 0.107 DBMET00888 0.448 0.005 DBMET00989 0.425 0.005 DBMET00992 0.315 0.015 DBMET00991 | DBMET00989 | |
| 0.486 | 0.066 | 0.625 | Caspase 9 stimulant | 0.51 0.056 DBMET00988 0.425 0.097 DBMET00990 0.455 0.08 DBMET00888 0.625 0.033 DBMET00989 0.625 0.033 DBMET00992 0.557 0.043 DBMET00991 | DBMET00992 | |
| 0.467 | 0.051 | 0.467 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.318 0.189 DBMET00988 0.307 0.203 DBMET00990 0.324 0.182 DBMET00888 0.324 0.182 DBMET00989 0.374 0.125 DBMET00992 0.421 0.083 DBMET00991 | ||
| 0.347 | 0.024 | 0.379 | RNA-directed DNA polymerase inhibitor | 0.238 0.057 DBMET00988 0.314 0.029 DBMET00990 0.264 0.042 DBMET00888 0.379 0.02 DBMET00989 0.364 0.022 DBMET00992 0.236 0.059 DBMET00991 | DBMET00989 | |
| 0.299 | 0.004 | 0.299 | Phosphodiesterase 7B inhibitor | 0.192 0.011 DBMET00988 0.181 0.013 DBMET00990 0.207 0.009 DBMET00989 0.237 0.007 DBMET00992 0.141 0.025 DBMET00991 | ||
| 0.346 | 0.054 | 0.412 | Spasmolytic | 0.235 0.098 DBMET00988 0.248 0.092 DBMET00990 0.412 0.038 DBMET00989 0.329 0.059 DBMET00992 0.271 0.082 DBMET00991 | DBMET00989 | |
| 0.275 | 0.003 | 0.275 | Phosphodiesterase VII inhibitor | 0.122 0.005 DBMET00988 0.126 0.005 DBMET00990 0.148 0.004 DBMET00989 0.173 0.004 DBMET00992 0.099 0.013 DBMET00991 | ||
| 0.311 | 0.052 | 0.763 | Cardiotonic | 0.24 0.09 DBMET00990 0.763 0.005 DBMET00888 0.253 0.08 DBMET00989 0.201 0.118 DBMET00992 | DBMET00888 | |
| 0.268 | 0.012 | 0.3 | UDP-glucose 4-epimerase inhibitor | 0.187 0.02 DBMET00988 0.3 0.01 DBMET00990 0.142 0.032 DBMET00888 0.243 0.014 DBMET00989 0.207 0.017 DBMET00992 0.193 0.019 DBMET00991 | DBMET00990 | |
| 0.366 | 0.111 | 0.398 | Cyclophilin D inhibitor | 0.376 0.105 DBMET00990 0.398 0.092 DBMET00989 0.299 0.164 DBMET00992 0.304 0.159 DBMET00991 | DBMET00989 | |
| 0.257 | 0.007 | 0.339 | Alcohol dehydrogenase inhibitor | 0.102 0.05 DBMET00988 0.145 0.022 DBMET00990 0.339 0.005 DBMET00989 0.215 0.011 DBMET00992 0.283 0.005 DBMET00991 | DBMET00989 | |
| 0.287 | 0.04 | 0.34 | Tyrosine 3 hydroxylase inhibitor | 0.186 0.164 DBMET00988 0.206 0.125 DBMET00990 0.34 0.018 DBMET00888 0.333 0.02 DBMET00989 0.264 0.056 DBMET00992 0.209 0.119 DBMET00991 | DBMET00888 | |
| 0.279 | 0.037 | 0.279 | Growth hormone agonist | 0.19 0.063 DBMET00988 0.25 0.043 DBMET00990 0.237 0.047 DBMET00989 0.225 0.05 DBMET00992 0.193 0.062 DBMET00991 | ||
| 0.368 | 0.13 | 0.433 | DNA directed DNA polymerase inhibitor | 0.248 0.193 DBMET00888 0.433 0.103 DBMET00989 0.383 0.123 DBMET00992 0.401 0.115 DBMET00991 | DBMET00989 | |
| 0.31 | 0.076 | 0.416 | Immunostimulant | 0.288 0.082 DBMET00988 0.416 0.045 DBMET00990 0.243 0.099 DBMET00888 0.325 0.072 DBMET00989 0.281 0.085 DBMET00992 0.338 0.068 DBMET00991 | DBMET00990 | |
| 0.268 | 0.039 | 0.335 | Peptidyltransferase inhibitor | 0.23 0.067 DBMET00988 0.335 0.015 DBMET00990 0.28 0.033 DBMET00989 0.234 0.063 DBMET00992 0.217 0.079 DBMET00991 | DBMET00990 | |
| 0.277 | 0.052 | 0.332 | DNA synthesis inhibitor | 0.225 0.088 DBMET00988 0.332 0.034 DBMET00990 0.222 0.092 DBMET00888 0.257 0.062 DBMET00989 0.243 0.071 DBMET00992 0.274 0.054 DBMET00991 | DBMET00990 | |
| 0.281 | 0.058 | 0.393 | Superoxide dismutase inhibitor | 0.2 0.118 DBMET00990 0.273 0.061 DBMET00888 0.393 0.028 DBMET00989 0.271 0.063 DBMET00992 0.223 0.095 DBMET00991 | DBMET00989 | |
| 0.231 | 0.012 | 0.231 | Nav1.6 sodium channel blocker | 0.134 0.074 DBMET00988 0.121 0.094 DBMET00990 0.168 0.037 DBMET00989 0.177 0.03 DBMET00992 | ||
| 0.234 | 0.016 | 0.234 | Ferrochelatase inhibitor | 0.088 0.086 DBMET00988 0.101 0.07 DBMET00990 0.093 0.079 DBMET00888 0.103 0.068 DBMET00989 0.105 0.066 DBMET00992 | ||
| 0.267 | 0.056 | 0.31 | Cyclic AMP phosphodiesterase inhibitor | 0.172 0.119 DBMET00988 0.229 0.075 DBMET00990 0.31 0.038 DBMET00989 0.238 0.07 DBMET00992 | DBMET00989 | |
| 0.258 | 0.046 | 0.462 | Peroxidase inhibitor | 0.127 0.093 DBMET00990 0.454 0.014 DBMET00888 0.462 0.013 DBMET00989 0.25 0.047 DBMET00992 0.111 0.11 DBMET00991 | DBMET00989 | |
| 0.212 | 0.014 | 0.212 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.127 0.035 DBMET00988 0.18 0.019 DBMET00990 0.088 0.069 DBMET00888 0.15 0.027 DBMET00989 0.133 0.033 DBMET00992 | ||
| 0.323 | 0.125 | 0.323 | Analgesic | |||
| 0.251 | 0.055 | 0.251 | Neuropeptide Y2 antagonist | 0.23 0.076 DBMET00888 0.212 0.1 DBMET00989 0.208 0.105 DBMET00992 | ||
| 0.279 | 0.085 | 0.527 | Nootropic | 0.527 0.016 DBMET00888 | DBMET00888 | |
| 0.22 | 0.029 | 0.261 | Alpha-N-acetylglucosaminidase inhibitor | 0.121 0.077 DBMET00988 0.261 0.021 DBMET00990 0.177 0.042 DBMET00888 0.15 0.055 DBMET00989 0.116 0.082 DBMET00992 | DBMET00990 | |
| 0.219 | 0.028 | 0.226 | Nav1.2 sodium channel blocker | 0.226 0.027 DBMET00988 0.139 0.064 DBMET00989 0.14 0.064 DBMET00992 | DBMET00988 | |
| 0.187 | 0.004 | 0.187 | Cathepsin E inhibitor | 0.115 0.01 DBMET00988 0.115 0.01 DBMET00990 0.148 0.005 DBMET00888 0.123 0.008 DBMET00989 0.132 0.007 DBMET00992 0.092 0.016 DBMET00991 | ||
| 0.178 | 0.003 | 0.178 | Phosphodiesterase 7A inhibitor | 0.088 0.005 DBMET00988 0.093 0.005 DBMET00990 0.11 0.004 DBMET00989 0.125 0.004 DBMET00992 0.074 0.009 DBMET00991 | ||
| 0.251 | 0.078 | 0.251 | Gastrin inhibitor | 0.203 0.144 DBMET00992 | ||
| 0.193 | 0.022 | 0.193 | GABA C receptor agonist | 0.112 0.056 DBMET00990 0.191 0.022 DBMET00888 0.142 0.037 DBMET00989 0.111 0.056 DBMET00992 | ||
| 0.198 | 0.03 | 0.198 | GABA C receptor rho-2 antagonist | 0.181 0.042 DBMET00888 0.169 0.051 DBMET00989 0.178 0.044 DBMET00992 | ||
| 0.194 | 0.027 | 0.194 | Nav1.3 sodium channel blocker | 0.19 0.028 DBMET00988 0.117 0.077 DBMET00989 0.127 0.067 DBMET00992 | ||
| 0.223 | 0.056 | 0.249 | Nitric-oxide synthase stimulant | 0.181 0.126 DBMET00988 0.204 0.082 DBMET00990 0.221 0.059 DBMET00888 0.249 0.033 DBMET00989 0.213 0.069 DBMET00992 | DBMET00989 | |
| 0.248 | 0.083 | 0.283 | 5 Hydroxytryptamine uptake stimulant | 0.189 0.175 DBMET00988 0.188 0.177 DBMET00990 0.25 0.081 DBMET00888 0.283 0.055 DBMET00989 0.235 0.097 DBMET00992 | DBMET00989 | |
| 0.319 | 0.155 | 0.374 | DNA polymerase beta inhibitor | 0.217 0.212 DBMET00888 0.374 0.129 DBMET00989 0.32 0.155 DBMET00992 0.352 0.138 DBMET00991 | DBMET00989 | |
| 0.239 | 0.075 | 0.291 | Vasodilator | 0.179 0.122 DBMET00990 0.291 0.051 DBMET00989 0.226 0.085 DBMET00992 | DBMET00989 | |
| 0.314 | 0.15 | 0.318 | 5 Hydroxytryptamine release inhibitor | 0.318 0.145 DBMET00888 0.296 0.169 DBMET00989 0.311 0.153 DBMET00992 | DBMET00888 | |
| 0.25 | 0.089 | 0.263 | 5 Hydroxytryptamine release stimulant | 0.263 0.083 DBMET00888 0.221 0.105 DBMET00989 0.232 0.098 DBMET00992 | DBMET00888 | |
| 0.158 | 0.009 | 0.463 | Phosphodiesterase III inhibitor | 0.463 0.003 DBMET00888 0.138 0.012 DBMET00989 0.138 0.012 DBMET00992 | DBMET00888 | |
| 0.15 | 0.009 | 0.15 | Biliverdin reductase inhibitor | 0.069 0.033 DBMET00988 0.137 0.011 DBMET00990 0.053 0.048 DBMET00888 0.087 0.023 DBMET00989 0.073 0.03 DBMET00992 | ||
| 0.153 | 0.017 | 0.163 | NADH dehydrogenase inhibitor | 0.114 0.032 DBMET00988 0.163 0.015 DBMET00990 0.115 0.032 DBMET00888 0.15 0.018 DBMET00989 0.131 0.023 DBMET00992 0.087 0.061 DBMET00991 | DBMET00990 | |
| 0.137 | 0.003 | 0.137 | Calcitonin gene-related peptide antagonist | 0.074 0.004 DBMET00988 0.071 0.004 DBMET00990 0.074 0.004 DBMET00989 0.081 0.003 DBMET00992 0.066 0.005 DBMET00991 | ||
| 0.158 | 0.025 | 0.158 | DNA repair enzyme inhibitor | 0.134 0.05 DBMET00990 0.109 0.098 DBMET00888 0.154 0.028 DBMET00989 0.145 0.036 DBMET00992 0.112 0.091 DBMET00991 | ||
| 0.131 | 0.003 | 0.131 | Calcitonin gene-related peptide 1 receptor antagonist | 0.061 0.004 DBMET00988 0.043 0.005 DBMET00990 0.077 0.004 DBMET00989 0.1 0.004 DBMET00992 0.031 0.005 DBMET00991 | ||
| 0.132 | 0.004 | 0.132 | Phospholipase D inhibitor | 0.102 0.013 DBMET00988 0.098 0.016 DBMET00990 0.085 0.028 DBMET00888 0.097 0.017 DBMET00989 0.098 0.016 DBMET00992 0.07 0.054 DBMET00991 | ||
| 0.268 | 0.143 | 0.396 | Histamine release inhibitor | 0.266 0.144 DBMET00888 0.396 0.078 DBMET00989 0.284 0.132 DBMET00992 | DBMET00989 | |
| 0.157 | 0.032 | 0.157 | 5 Hydroxytryptamine 3A agonist | 0.104 0.071 DBMET00888 0.113 0.062 DBMET00989 0.131 0.047 DBMET00992 | ||
| 0.147 | 0.025 | 0.147 | DNA directed RNA polymerase inhibitor | 0.105 0.051 DBMET00988 0.1 0.057 DBMET00990 0.104 0.052 DBMET00989 0.129 0.032 DBMET00992 0.089 0.07 DBMET00991 | ||
| 0.194 | 0.072 | 0.194 | 5 Hydroxytryptamine 3E antagonist | 0.183 0.099 DBMET00992 | ||
| 0.229 | 0.118 | 0.239 | Insulysin inhibitor | 0.226 0.122 DBMET00888 0.239 0.107 DBMET00989 0.187 0.177 DBMET00992 | DBMET00989 | |
| 0.171 | 0.06 | 0.171 | Cyclin-dependent kinase 8 inhibitor | 0.131 0.101 DBMET00989 | ||
| 0.14 | 0.029 | 0.244 | HIV-1 integrase (Overall Integration) inhibitor | 0.088 0.067 DBMET00990 0.244 0.005 DBMET00888 0.184 0.015 DBMET00989 0.111 0.045 DBMET00992 0.099 0.055 DBMET00991 | DBMET00888 | |
| 0.171 | 0.06 | 0.177 | Neurotensin receptor agonist | 0.157 0.086 DBMET00888 0.177 0.053 DBMET00989 0.156 0.088 DBMET00992 | DBMET00989 | |
| 0.127 | 0.019 | 0.127 | Bromodomain-containing protein 2 inhibitor | 0.09 0.055 DBMET00989 0.116 0.025 DBMET00992 | ||
| 0.252 | 0.145 | 0.252 | Calcium channel activator | 0.208 0.202 DBMET00888 0.218 0.187 DBMET00992 | ||
| 0.161 | 0.055 | 0.205 | Mannose-6-phosphate isomerase inhibitor | 0.121 0.098 DBMET00990 0.205 0.028 DBMET00888 0.185 0.039 DBMET00989 0.18 0.042 DBMET00992 0.146 0.068 DBMET00991 | DBMET00888 | |
| 0.156 | 0.05 | 0.156 | Sodium channel (voltage-gated) blocker | 0.126 0.078 DBMET00992 | ||
| 0.148 | 0.047 | 0.151 | Ca2+-transporting ATPase inhibitor | 0.138 0.081 DBMET00988 0.148 0.046 DBMET00990 0.151 0.04 DBMET00888 0.141 0.068 DBMET00989 0.134 0.098 DBMET00992 | DBMET00888 | |
| 0.112 | 0.013 | 0.112 | Secretase beta inhibitor | 0.067 0.056 DBMET00988 0.072 0.047 DBMET00990 0.072 0.046 DBMET00888 0.087 0.028 DBMET00989 0.082 0.034 DBMET00992 | ||
| 0.126 | 0.027 | 0.127 | Metalloproteinase-2 inhibitor | 0.074 0.06 DBMET00990 0.127 0.026 DBMET00989 0.11 0.034 DBMET00992 | DBMET00989 | |
| 0.174 | 0.075 | 0.215 | Succinate dehydrogenase inhibitor | 0.215 0.038 DBMET00888 0.205 0.045 DBMET00989 0.166 0.086 DBMET00992 0.148 0.116 DBMET00991 | DBMET00888 | |
| 0.122 | 0.024 | 0.126 | Metalloproteinase-9 inhibitor | 0.068 0.059 DBMET00990 0.126 0.023 DBMET00989 0.105 0.03 DBMET00992 | DBMET00989 | |
| 0.14 | 0.045 | 0.261 | Cystathionine beta-synthase inhibitor | 0.113 0.064 DBMET00990 0.224 0.019 DBMET00888 0.261 0.014 DBMET00989 0.164 0.035 DBMET00992 0.113 0.064 DBMET00991 | DBMET00989 | |
| 0.108 | 0.013 | 0.108 | NMDA receptor glycine site agonist | 0.083 0.026 DBMET00989 0.083 0.026 DBMET00992 | ||
| 0.128 | 0.034 | 0.128 | GABA C receptor rho-1 antagonist | 0.107 0.053 DBMET00888 0.095 0.069 DBMET00989 0.097 0.067 DBMET00992 | ||
| 0.119 | 0.028 | 0.119 | Phosphodiesterase I inhibitor | 0.095 0.051 DBMET00990 0.107 0.037 DBMET00989 0.098 0.047 DBMET00992 | ||
| 0.104 | 0.013 | 0.117 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.066 0.029 DBMET00988 0.117 0.011 DBMET00990 0.076 0.022 DBMET00888 0.074 0.023 DBMET00989 0.062 0.033 DBMET00992 0.05 0.048 DBMET00991 | DBMET00990 | |
| 0.104 | 0.015 | 0.104 | Collagenase 3 inhibitor | 0.075 0.028 DBMET00989 0.078 0.025 DBMET00992 | ||
| 0.095 | 0.011 | 0.095 | Phosphodiesterase 1A inhibitor | 0.065 0.031 DBMET00989 0.067 0.028 DBMET00992 | ||
| 0.122 | 0.039 | 0.219 | Creatine kinase inhibitor | 0.112 0.048 DBMET00990 0.219 0.008 DBMET00888 0.209 0.009 DBMET00989 0.136 0.03 DBMET00992 | DBMET00888 | |
| 0.09 | 0.007 | 0.092 | Dihydroorotate oxidase inhibitor | 0.051 0.049 DBMET00988 0.057 0.034 DBMET00990 0.092 0.006 DBMET00989 0.076 0.013 DBMET00992 0.062 0.027 DBMET00991 | DBMET00989 | |
| 0.1 | 0.021 | 0.109 | Carbamoyl phosphate synthetase inhibitor | 0.057 0.046 DBMET00988 0.109 0.018 DBMET00990 0.075 0.031 DBMET00888 0.074 0.032 DBMET00989 0.059 0.044 DBMET00992 | DBMET00990 | |
| 0.126 | 0.047 | 0.139 | GABA C receptor antagonist | 0.139 0.037 DBMET00888 0.098 0.082 DBMET00989 | DBMET00888 | |
| 0.116 | 0.04 | 0.116 | Electrolyte absorption antagonist | |||
| 0.095 | 0.021 | 0.095 | NMDA receptor agonist | 0.066 0.039 DBMET00989 0.061 0.045 DBMET00992 | ||
| 0.119 | 0.045 | 0.124 | Adenylate kinase inhibitor | 0.124 0.04 DBMET00990 0.107 0.057 DBMET00888 0.094 0.078 DBMET00989 | DBMET00990 | |
| 0.102 | 0.029 | 0.168 | Keratolytic | 0.087 0.04 DBMET00990 0.091 0.037 DBMET00888 0.168 0.012 DBMET00989 0.099 0.031 DBMET00992 0.089 0.038 DBMET00991 | DBMET00989 | |
| 0.104 | 0.03 | 0.141 | Phosphofructokinase-1 inhibitor | 0.069 0.048 DBMET00988 0.12 0.025 DBMET00990 0.083 0.039 DBMET00888 0.089 0.036 DBMET00989 0.066 0.051 DBMET00992 0.141 0.02 DBMET00991 | DBMET00991 | |
| 0.093 | 0.021 | 0.093 | Argininosuccinate synthase inhibitor | 0.093 0.021 DBMET00990 0.064 0.034 DBMET00989 0.065 0.033 DBMET00992 | ||
| 0.106 | 0.035 | 0.106 | Interleukin 5 antagonist | 0.086 0.062 DBMET00988 0.091 0.053 DBMET00990 0.084 0.065 DBMET00888 0.096 0.046 DBMET00989 0.099 0.043 DBMET00992 | ||
| 0.086 | 0.015 | 0.086 | Phosphodiesterase 1C inhibitor | 0.058 0.055 DBMET00888 0.078 0.021 DBMET00989 0.069 0.031 DBMET00992 | ||
| 0.089 | 0.018 | 0.095 | Glutamate (mGluR7) antagonist | 0.068 0.046 DBMET00988 0.095 0.014 DBMET00888 0.077 0.032 DBMET00989 0.081 0.026 DBMET00992 | DBMET00888 | |
| 0.108 | 0.041 | 0.108 | Triose-phosphate isomerase inhibitor | 0.105 0.043 DBMET00990 0.099 0.049 DBMET00888 0.089 0.061 DBMET00989 0.091 0.058 DBMET00992 | ||
| 0.099 | 0.033 | 0.099 | Glycine receptor antagonist | 0.09 0.043 DBMET00988 0.096 0.036 DBMET00990 0.078 0.061 DBMET00989 | ||
| 0.069 | 0.004 | 0.069 | Uridine phosphorylase inhibitor | 0.049 0.008 DBMET00988 0.066 0.005 DBMET00990 0.065 0.005 DBMET00888 0.059 0.005 DBMET00989 0.051 0.008 DBMET00992 0.026 0.021 DBMET00991 | ||
| 0.082 | 0.017 | 0.082 | MDM2 inhibitor | 0.072 0.034 DBMET00990 0.067 0.047 DBMET00989 0.072 0.033 DBMET00992 | ||
| 0.091 | 0.026 | 0.091 | Neutrophil collagenase inhibitor | 0.086 0.028 DBMET00989 0.083 0.03 DBMET00992 | ||
| 0.083 | 0.021 | 0.083 | Phosphodiesterase 1B inhibitor | 0.068 0.033 DBMET00989 0.062 0.039 DBMET00992 | ||
| 0.091 | 0.031 | 0.091 | Matrix metalloproteinase inhibitor | 0.085 0.034 DBMET00989 0.087 0.033 DBMET00992 | ||
| 0.132 | 0.072 | 0.132 | Sodium channel blocker | |||
| 0.096 | 0.038 | 0.096 | Alpha 1a adrenoreceptor antagonist | 0.073 0.049 DBMET00989 0.063 0.055 DBMET00992 | ||
| 0.169 | 0.11 | 0.219 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.169 0.11 DBMET00990 0.219 0.059 DBMET00888 0.216 0.06 DBMET00989 0.208 0.066 DBMET00992 | DBMET00888 | |
| 0.186 | 0.128 | 0.254 | DNA damaging | 0.186 0.127 DBMET00990 0.161 0.156 DBMET00888 0.224 0.097 DBMET00989 0.254 0.078 DBMET00992 | DBMET00992 | |
| 0.086 | 0.029 | 0.095 | Acetylcholine M5 receptor agonist | 0.095 0.023 DBMET00992 | DBMET00992 | |
| 0.153 | 0.097 | 0.153 | 3C-like protease (Human coronavirus) inhibitor | 0.144 0.111 DBMET00992 0.146 0.108 DBMET00991 | ||
| 0.081 | 0.026 | 0.081 | Cannabinoid CB1 receptor antagonist | |||
| 0.139 | 0.083 | 0.166 | Adenylate cyclase stimulant | 0.162 0.044 DBMET00990 0.144 0.073 DBMET00888 0.166 0.039 DBMET00989 0.138 0.085 DBMET00992 | DBMET00989 | |
| 0.079 | 0.025 | 0.159 | Alcohol oxidase inhibitor | 0.083 0.023 DBMET00990 0.159 0.009 DBMET00888 0.084 0.023 DBMET00989 0.059 0.036 DBMET00992 | DBMET00888 | |
| 0.107 | 0.054 | 0.142 | Anabolic | 0.142 0.022 DBMET00990 0.105 0.056 DBMET00888 0.118 0.041 DBMET00989 0.126 0.034 DBMET00992 0.126 0.034 DBMET00991 | DBMET00990 | |
| 0.077 | 0.024 | 0.089 | Carbonic anhydrase VB inhibitor | 0.089 0.019 DBMET00989 0.055 0.04 DBMET00992 | DBMET00989 | |
| 0.057 | 0.005 | 0.062 | Protein kinase (CK2) beta inhibitor | 0.031 0.029 DBMET00990 0.062 0.005 DBMET00989 0.04 0.012 DBMET00992 0.041 0.012 DBMET00991 | DBMET00989 | |
| 0.078 | 0.027 | 0.078 | Glutamate (mGluR6) antagonist | 0.07 0.04 DBMET00990 0.073 0.033 DBMET00888 0.063 0.057 DBMET00989 0.062 0.06 DBMET00992 | ||
| 0.063 | 0.013 | 0.064 | Thymidine kinase inhibitor | 0.041 0.028 DBMET00988 0.064 0.012 DBMET00990 0.048 0.02 DBMET00989 0.045 0.023 DBMET00992 | DBMET00990 | |
| 0.084 | 0.035 | 0.186 | Phenylalanine 4-hydroxylase inhibitor | 0.063 0.054 DBMET00990 0.186 0.008 DBMET00888 0.132 0.015 DBMET00989 | DBMET00888 | |
| 0.076 | 0.028 | 0.076 | NMDA 2C receptor antagonist | 0.073 0.03 DBMET00989 0.059 0.046 DBMET00992 | ||
| 0.056 | 0.009 | 0.056 | Kainate receptor agonist | 0.041 0.029 DBMET00988 0.05 0.014 DBMET00990 0.04 0.033 DBMET00888 0.047 0.017 DBMET00989 0.042 0.027 DBMET00992 | ||
| 0.088 | 0.042 | 0.089 | CC chemokine 5 receptor agonist | 0.081 0.06 DBMET00888 0.089 0.039 DBMET00989 0.079 0.067 DBMET00992 | DBMET00989 | |
| 0.148 | 0.104 | 0.202 | ATPase inhibitor | 0.192 0.044 DBMET00988 0.202 0.035 DBMET00990 0.154 0.095 DBMET00989 | DBMET00990 | |
| 0.107 | 0.063 | 0.167 | DOPA decarboxylase inhibitor | 0.167 0.014 DBMET00888 0.156 0.018 DBMET00989 0.116 0.05 DBMET00992 0.116 0.05 DBMET00991 | DBMET00888 | |
| 0.048 | 0.004 | 0.048 | Nicotinic acid receptor 2 antagonist | 0.025 0.022 DBMET00988 0.024 0.023 DBMET00990 0.036 0.007 DBMET00989 0.04 0.005 DBMET00992 | ||
| 0.049 | 0.005 | 0.049 | Nociceptin (N/OFQ) receptor agonist | |||
| 0.079 | 0.037 | 0.09 | Carbonic anhydrase VA inhibitor | 0.073 0.043 DBMET00888 0.09 0.03 DBMET00989 0.062 0.057 DBMET00992 | DBMET00989 | |
| 0.043 | 0.006 | 0.043 | Thymidine phosphorylase inhibitor | 0.026 0.019 DBMET00988 0.035 0.008 DBMET00990 0.034 0.009 DBMET00888 0.033 0.009 DBMET00989 0.027 0.017 DBMET00992 | ||
| 0.081 | 0.044 | 0.124 | Glutamate decarboxylase inhibitor | 0.124 0.019 DBMET00888 0.104 0.027 DBMET00989 0.065 0.062 DBMET00992 | DBMET00888 | |
| 0.083 | 0.045 | 0.188 | Porphobilinogen synthase inhibitor | 0.126 0.026 DBMET00888 0.088 0.042 DBMET00989 0.188 0.014 DBMET00991 | DBMET00991 | |
| 0.078 | 0.041 | 0.078 | Cannabinoid receptor antagonist | |||
| 0.137 | 0.101 | 0.16 | CF transmembrane conductance regulator agonist | 0.16 0.06 DBMET00888 0.128 0.122 DBMET00989 | DBMET00888 | |
| 0.178 | 0.141 | 0.18 | Interleukin agonist | 0.18 0.139 DBMET00989 | DBMET00989 | |
| 0.05 | 0.014 | 0.05 | Nicotinic acid receptor agonist | 0.045 0.017 DBMET00989 0.035 0.026 DBMET00992 0.04 0.02 DBMET00991 | ||
| 0.107 | 0.072 | 0.107 | Acetylcholine release stimulant | |||
| 0.089 | 0.054 | 0.111 | Granulocyte macrophage colony stimulating factor agonist | 0.096 0.041 DBMET00888 0.104 0.03 DBMET00989 0.082 0.071 DBMET00992 0.111 0.023 DBMET00991 | DBMET00991 | |
| 0.059 | 0.025 | 0.059 | Bombesin 2 receptor antagonist | 0.047 0.039 DBMET00989 0.046 0.039 DBMET00992 | ||
| 0.063 | 0.03 | 0.072 | Ryanodine receptor antagonist | 0.056 0.052 DBMET00990 0.06 0.038 DBMET00888 0.072 0.015 DBMET00989 0.065 0.026 DBMET00992 | DBMET00989 | |
| 0.083 | 0.051 | 0.083 | Alpha 1 adrenoreceptor antagonist | 0.068 0.061 DBMET00989 | ||
| 0.051 | 0.02 | 0.051 | Nicotinic acid receptor 1 agonist | |||
| 0.078 | 0.047 | 0.078 | Glutamate dehydrogenase inhibitor | 0.077 0.048 DBMET00990 0.067 0.061 DBMET00888 0.075 0.05 DBMET00991 | ||
| 0.072 | 0.041 | 0.087 | Carbonic anhydrase V inhibitor | 0.066 0.046 DBMET00888 0.087 0.032 DBMET00989 | DBMET00989 | |
| 0.058 | 0.028 | 0.06 | Aconitate hydratase inhibitor | 0.06 0.026 DBMET00888 | DBMET00888 | |
| 0.06 | 0.031 | 0.06 | Ornithine carbamoyltransferase inhibitor | 0.056 0.034 DBMET00990 | ||
| 0.075 | 0.046 | 0.075 | Glycine receptor agonist | 0.074 0.048 DBMET00990 0.067 0.06 DBMET00888 0.066 0.063 DBMET00989 | ||
| 0.127 | 0.099 | 0.127 | Acetylcholine M1 receptor antagonist | 0.116 0.114 DBMET00989 | ||
| 0.04 | 0.012 | 0.04 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.033 0.015 DBMET00990 | ||
| 0.06 | 0.033 | 0.06 | Matrix metalloproteinase (membrane-type) inhibitor | 0.054 0.039 DBMET00989 0.059 0.033 DBMET00992 | ||
| 0.049 | 0.022 | 0.049 | Glutamate (mGluR4) antagonist | |||
| 0.051 | 0.026 | 0.051 | Thymidylate synthase inhibitor | |||
| 0.059 | 0.034 | 0.064 | Pregnane X receptor antagonist | 0.053 0.05 DBMET00989 0.064 0.023 DBMET00991 | DBMET00991 | |
| 0.033 | 0.008 | 0.033 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.024 DBMET00988 0.033 0.008 DBMET00990 0.027 0.016 DBMET00989 0.028 0.015 DBMET00992 | ||
| 0.083 | 0.059 | 0.109 | D-Ala-D-Ala ligase inhibitor | 0.107 0.022 DBMET00888 0.109 0.02 DBMET00989 0.083 0.06 DBMET00992 0.078 0.073 DBMET00991 | DBMET00989 | |
| 0.093 | 0.07 | 0.101 | Aminopeptidase B inhibitor | 0.101 0.064 DBMET00888 | DBMET00888 | |
| 0.031 | 0.008 | 0.031 | Acid ceramidase inhibitor | |||
| 0.028 | 0.005 | 0.028 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.027 0.005 DBMET00990 0.022 0.011 DBMET00989 0.023 0.01 DBMET00992 | ||
| 0.033 | 0.01 | 0.041 | DNA polymerase III inhibitor | 0.041 0.005 DBMET00888 | DBMET00888 | |
| 0.041 | 0.018 | 0.042 | Fumarate hydratase inhibitor | 0.042 0.017 DBMET00990 | DBMET00990 | |
| 0.105 | 0.083 | 0.14 | Alkylator | 0.14 0.052 DBMET00990 0.117 0.071 DBMET00989 0.124 0.064 DBMET00992 | DBMET00990 | |
| 0.128 | 0.106 | 0.128 | Sphingosine 1-phosphate receptor 5 antagonist | 0.126 0.11 DBMET00989 | ||
| 0.041 | 0.02 | 0.041 | Nicotinic acid receptor 2 agonist | 0.037 0.024 DBMET00989 0.035 0.026 DBMET00991 | ||
| 0.071 | 0.05 | 0.163 | Histidine decarboxylase inhibitor | 0.115 0.027 DBMET00888 0.126 0.024 DBMET00989 0.066 0.054 DBMET00992 0.163 0.017 DBMET00991 | DBMET00991 | |
| 0.196 | 0.176 | 0.236 | Thioredoxin glutathione reductase inhibitor | 0.236 0.144 DBMET00988 0.212 0.162 DBMET00989 0.192 0.179 DBMET00992 0.234 0.146 DBMET00991 | DBMET00988 | |
| 0.037 | 0.019 | 0.037 | Purinergic P2Y2 antagonist | 0.031 0.027 DBMET00992 | ||
| 0.053 | 0.035 | 0.057 | NMDA 2A receptor antagonist | 0.057 0.031 DBMET00989 | DBMET00989 | |
| 0.087 | 0.07 | 0.111 | Prolactin inhibitor | 0.101 0.054 DBMET00888 0.111 0.045 DBMET00989 | DBMET00989 | |
| 0.045 | 0.028 | 0.045 | Macrophage elastase inhibitor | |||
| 0.068 | 0.051 | 0.069 | HIV-1 reverse transcriptase inhibitor | 0.069 0.05 DBMET00989 | DBMET00989 | |
| 0.022 | 0.006 | 0.024 | Thyroid hormone alpha agonist | 0.015 0.014 DBMET00990 0.024 0.005 DBMET00989 0.018 0.008 DBMET00992 0.021 0.006 DBMET00991 | DBMET00989 | |
| 0.152 | 0.136 | 0.152 | Histone acetyltransferase inhibitor | 0.152 0.137 DBMET00989 | ||
| 0.017 | 0.002 | 0.017 | DNA topoisomerase III inhibitor | 0.007 0.006 DBMET00988 0.009 0.004 DBMET00990 0.012 0.003 DBMET00888 0.01 0.004 DBMET00989 0.009 0.004 DBMET00992 | ||
| 0.058 | 0.043 | 0.088 | Androgen agonist | 0.088 0.02 DBMET00990 0.064 0.036 DBMET00989 0.056 0.046 DBMET00992 | DBMET00990 | |
| 0.053 | 0.039 | 0.117 | Cathepsin D inhibitor | 0.117 0.013 DBMET00888 | DBMET00888 | |
| 0.027 | 0.013 | 0.027 | Glutamate (mGluR1) agonist | |||
| 0.037 | 0.023 | 0.037 | Nociceptin (N/OFQ) receptor antagonist | |||
| 0.025 | 0.012 | 0.025 | Glutamate (mGluR1a) agonist | |||
| 0.099 | 0.085 | 0.143 | Adenylate cyclase inhibitor | 0.125 0.063 DBMET00990 0.143 0.05 DBMET00989 | DBMET00989 | |
| 0.235 | 0.222 | 0.301 | Calcium channel L-type activator | 0.297 0.16 DBMET00888 0.301 0.157 DBMET00989 0.262 0.193 DBMET00992 | DBMET00989 | |
| 0.044 | 0.032 | 0.046 | Dihydroorotase inhibitor | 0.046 0.029 DBMET00989 | DBMET00989 | |
| 0.043 | 0.032 | 0.043 | Glutamate (mGluR group III) antagonist | |||
| 0.039 | 0.029 | 0.079 | Dopamine D5 agonist | 0.065 0.01 DBMET00888 0.079 0.006 DBMET00989 0.038 0.03 DBMET00992 | DBMET00989 | |
| 0.059 | 0.049 | 0.059 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.197 | 0.187 | 0.197 | Beta lactamase inhibitor | |||
| 0.08 | 0.072 | 0.08 | Alpha adrenoreceptor antagonist | 0.076 0.075 DBMET00989 | ||
| 0.088 | 0.08 | 0.096 | Phosphodiesterase 6D inhibitor | 0.096 0.06 DBMET00989 | DBMET00989 | |
| 0.15 | 0.142 | 0.336 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.336 0.054 DBMET00888 0.221 0.089 DBMET00989 0.202 0.099 DBMET00992 | DBMET00888 | |
| 0.043 | 0.035 | 0.052 | Phosphorylase inhibitor | 0.039 0.038 DBMET00989 0.052 0.029 DBMET00991 | DBMET00991 | |
| 0.065 | 0.057 | 0.065 | Alpha 1b adrenoreceptor antagonist | |||
| 0.014 | 0.007 | 0.014 | DNA polymerase III polC-type inhibitor | |||
| 0.125 | 0.119 | 0.166 | Arachidonic acid antagonist | 0.137 0.103 DBMET00990 0.166 0.07 DBMET00888 0.165 0.071 DBMET00989 0.144 0.096 DBMET00992 | DBMET00888 | |
| 0.069 | 0.063 | 0.069 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.039 | 0.035 | 0.039 | Angiotensin AT1 receptor antagonist | |||
| 0.044 | 0.04 | 0.056 | Glucose-6-phosphate isomerase inhibitor | 0.056 0.022 DBMET00990 0.048 0.032 DBMET00888 | DBMET00990 | |
| 0.051 | 0.048 | 0.051 | Alpha 1d adrenoreceptor antagonist | |||
| 0.042 | 0.038 | 0.042 | Antimetabolite | 0.042 0.039 DBMET00990 | ||
| 0.012 | 0.009 | 0.018 | Egl nine homolog 3 inhibitor | 0.018 0.005 DBMET00888 0.011 0.009 DBMET00989 | DBMET00888 | |
| 0.038 | 0.035 | 0.038 | Plasmepsin II inhibitor | |||
| 0.032 | 0.031 | 0.032 | Growth factor receptor-bound protein 2 antagonist | |||
| 0.047 | 0.046 | 0.047 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.024 | 0.023 | 0.024 | Integrin alpha2beta1 antagonist | |||
| 0.036 | 0.035 | 0.036 | Aggrecanase 1 inhibitor | |||
| 0.054 | 0.053 | 0.054 | TRPA1 antagonist | |||
| 0.129 | 0.128 | 0.139 | Heat shock protein 70 antagonist | 0.139 0.079 DBMET00989 0.135 0.097 DBMET00992 | DBMET00989 | |
| 0.009 | 0.01 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.009 DBMET00990 | DBMET00990 | |
| 0.08 | 0.083 | 0.097 | Protein kinase (CK2) inhibitor | 0.097 0.066 DBMET00989 | DBMET00989 | |
| 0.023 | 0.025 | 0.036 | Thyroid hormone agonist | 0.036 0.008 DBMET00989 | DBMET00989 | |
| 0.089 | 0.095 | 0.133 | Mucolytic | 0.133 0.043 DBMET00990 0.115 0.059 DBMET00989 0.118 0.056 DBMET00991 | DBMET00990 | |
| 0.076 | 0.083 | 0.1 | Estrogen-related receptor beta agonist | 0.1 0.024 DBMET00888 0.088 0.046 DBMET00989 | DBMET00888 | |
| 0.113 | 0.123 | 0.136 | Insulin secretagoues | 0.12 0.111 DBMET00990 0.136 0.09 DBMET00989 | DBMET00989 | |
| 0.081 | 0.091 | 0.241 | Xanthine oxidase inhibitor | 0.207 0.018 DBMET00888 0.15 0.034 DBMET00989 0.108 0.054 DBMET00992 0.241 0.013 DBMET00991 | DBMET00991 | |
| 0.092 | 0.103 | 0.295 | M18 aspartyl aminopeptidase inhibitor | 0.154 0.05 DBMET00888 0.295 0.013 DBMET00989 0.103 0.088 DBMET00992 | DBMET00989 | |
| 0.067 | 0.079 | 0.102 | Carbonic anhydrase VI inhibitor | 0.102 0.038 DBMET00989 | DBMET00989 | |
| 0.004 | 0.021 | 0.008 | Thyroid hormone beta agonist | 0.008 0.006 DBMET00989 | DBMET00989 | |
| 0.067 | 0.086 | 0.12 | NMDA receptor antagonist | 0.12 0.036 DBMET00888 0.082 0.063 DBMET00989 | DBMET00888 | |
| 0.094 | 0.113 | 0.108 | Interleukin 8 antagonist | 0.108 0.08 DBMET00989 | DBMET00989 | |
| 0.052 | 0.071 | 0.085 | Lipase inhibitor | 0.078 0.045 DBMET00989 0.085 0.038 DBMET00992 | DBMET00992 | |
| 0.045 | 0.065 | 0.057 | Fatty acid synthase inhibitor | 0.057 0.04 DBMET00989 | DBMET00989 | |
| 0.027 | 0.048 | 0.051 | Glutamate (mGluR3) antagonist | 0.051 0.012 DBMET00888 | DBMET00888 | |
| 0.065 | 0.087 | 0.075 | GABA B receptor agonist | 0.073 0.061 DBMET00888 0.075 0.053 DBMET00989 | DBMET00989 | |
| 0.059 | 0.081 | 0.077 | Analgesic, opioid | 0.077 0.052 DBMET00990 0.071 0.059 DBMET00989 | DBMET00990 | |
| 0.008 | 0.031 | 0.014 | Egl nine homolog 1 inhibitor | 0.014 0.011 DBMET00888 | DBMET00888 | |
| 0.179 | 0.202 | 0.201 | Vasodilator, coronary | 0.199 0.183 DBMET00989 0.201 0.181 DBMET00992 | DBMET00992 | |
| 0.056 | 0.081 | 0.125 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.092 0.042 DBMET00989 0.125 0.027 DBMET00991 | DBMET00991 | |
| 0.136 | 0.161 | 0.212 | Neurotrophic factor enhancer | 0.205 0.072 DBMET00888 0.203 0.074 DBMET00989 0.212 0.066 DBMET00991 | DBMET00991 | |
| 0.034 | 0.06 | 0.038 | CF transmembrane conductance regulator antagonist | 0.038 0.033 DBMET00888 | DBMET00888 | |
| 0.109 | 0.137 | 0.136 | Hexokinase inhibitor | 0.124 0.112 DBMET00990 0.136 0.096 DBMET00992 | DBMET00992 | |
| 0.04 | 0.069 | 0.048 | Alpha-mannosidase inhibitor | 0.048 0.047 DBMET00990 | DBMET00990 | |
| 0.046 | 0.077 | 0.132 | Purinergic P2X1 antagonist | 0.132 0.009 DBMET00888 0.081 0.024 DBMET00991 | DBMET00888 | |
| 0.051 | 0.083 | 0.088 | Carbonic anhydrase XIII inhibitor | 0.088 0.044 DBMET00989 0.069 0.059 DBMET00991 | DBMET00989 | |
| 0.028 | 0.06 | 0.042 | Carbonic anhydrase VII inhibitor | 0.042 0.037 DBMET00989 | DBMET00989 | |
| 0.028 | 0.062 | 0.125 | NMDA receptor subunit 3B antagonist | 0.125 0.008 DBMET00888 | DBMET00888 | |
| 0.024 | 0.059 | 0.032 | Glutamate (mGluR3) agonist | 0.032 0.023 DBMET00888 | DBMET00888 | |
| 0.165 | 0.202 | 0.224 | Cholesterol antagonist | 0.217 0.15 DBMET00990 0.224 0.145 DBMET00888 0.216 0.151 DBMET00989 | DBMET00888 | |
| 0.066 | 0.103 | 0.087 | MAP kinase kinase 7 inhibitor | 0.087 0.03 DBMET00888 0.078 0.052 DBMET00989 | DBMET00888 | |
| 0.055 | 0.098 | 0.071 | GABA aminotransferase inhibitor | 0.071 0.061 DBMET00888 0.068 0.065 DBMET00991 | DBMET00888 | |
| 0.002 | 0.049 | 0.006 | DNA polymerase III subunit alpha inhibitor | 0.006 0.005 DBMET00888 | DBMET00888 | |
| 0.124 | 0.172 | 0.158 | Phospholipase C inhibitor | 0.151 0.104 DBMET00888 0.143 0.12 DBMET00989 0.158 0.092 DBMET00991 | DBMET00991 | |
| 0.019 | 0.069 | 0.084 | NMDA receptor subunit 3A antagonist | 0.084 0.01 DBMET00888 | DBMET00888 | |
| 0.014 | 0.065 | 0.02 | Granulocyte colony stimulating factor receptor agonist | 0.02 0.009 DBMET00991 | DBMET00991 | |
| 0.051 | 0.103 | 0.061 | Beta 2 adrenoreceptor agonist | 0.061 0.044 DBMET00989 | DBMET00989 | |
| 0.074 | 0.127 | 0.106 | AMP-activated protein kinase stimulant | 0.106 0.063 DBMET00990 0.092 0.082 DBMET00989 | DBMET00990 | |
| 0.074 | 0.128 | 0.123 | Beta glucuronidase inhibitor | 0.092 0.083 DBMET00888 0.11 0.056 DBMET00989 0.123 0.043 DBMET00991 | DBMET00991 | |
| 0.067 | 0.121 | 0.134 | Expectorant | 0.134 0.042 DBMET00990 0.096 0.074 DBMET00989 0.094 0.076 DBMET00991 | DBMET00990 | |
| 0.02 | 0.081 | 0.037 | Dihydropteroate synthase inhibitor | 0.037 0.031 DBMET00888 | DBMET00888 | |
| 0.026 | 0.091 | 0.1 | Xanthine dehydrogenase inhibitor | 0.1 0.015 DBMET00888 0.064 0.036 DBMET00989 0.099 0.016 DBMET00991 | DBMET00888 | |
| 0.034 | 0.1 | 0.043 | Beta adrenoreceptor agonist | 0.043 0.041 DBMET00989 | DBMET00989 | |
| 0.046 | 0.114 | 0.067 | Beta 3 adrenoreceptor antagonist | 0.067 0.038 DBMET00888 0.061 0.053 DBMET00989 | DBMET00888 | |
| 0.1 | 0.176 | 0.126 | Neuropeptide Y1 antagonist | 0.126 0.109 DBMET00888 | DBMET00888 | |
| 0.019 | 0.098 | 0.465 | Phosphodiesterase 3B inhibitor | 0.465 0.002 DBMET00888 | DBMET00888 | |
| 0.166 | 0.247 | 0.362 | Alpha-glucosidase inhibitor | 0.219 0.207 DBMET00888 0.307 0.156 DBMET00989 0.362 0.13 DBMET00991 | DBMET00991 | |
| 0.048 | 0.129 | 0.081 | Adrenaline agonist | 0.081 0.057 DBMET00989 | DBMET00989 | |
| 0.103 | 0.186 | 0.141 | Interferon gamma antagonist | 0.127 0.117 DBMET00888 0.129 0.112 DBMET00989 0.141 0.091 DBMET00991 | DBMET00991 | |
| 0.035 | 0.123 | 0.081 | Glucosylceramidase inhibitor | 0.081 0.015 DBMET00888 | DBMET00888 | |
| 0.073 | 0.163 | 0.106 | TRPA1 agonist | 0.106 0.078 DBMET00991 | DBMET00991 | |
| 0.052 | 0.144 | 0.104 | Bronchodilator | 0.104 0.059 DBMET00989 | DBMET00989 | |
| 0.108 | 0.201 | 0.163 | Lipocortins synthesis antagonist | 0.163 0.088 DBMET00990 0.142 0.117 DBMET00989 0.156 0.097 DBMET00992 | DBMET00990 | |
| 0.071 | 0.172 | 0.117 | Aldehyde dehydrogenase inhibitor | 0.104 0.091 DBMET00888 0.117 0.074 DBMET00991 | DBMET00991 | |
| 0.043 | 0.145 | 0.141 | Phosphodiesterase 3A inhibitor | 0.141 0.017 DBMET00888 | DBMET00888 | |
| 0.124 | 0.227 | 0.221 | Hypoglycemic | 0.206 0.107 DBMET00990 0.221 0.095 DBMET00989 | DBMET00989 | |
| 0.096 | 0.2 | 0.151 | Melanin inhibitor | 0.145 0.088 DBMET00888 0.139 0.097 DBMET00989 0.151 0.08 DBMET00991 | DBMET00991 | |
| 0.027 | 0.132 | 0.06 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.056 0.034 DBMET00888 0.06 0.03 DBMET00991 | DBMET00991 | |
| 0.042 | 0.151 | 0.193 | Monophenol monooxygenase inhibitor | 0.114 0.066 DBMET00989 0.193 0.035 DBMET00991 | DBMET00991 | |
| 0.06 | 0.169 | 0.12 | Amylase inhibitor | 0.12 0.081 DBMET00989 | DBMET00989 | |
| 0.009 | 0.118 | 0.029 | Dopamine D1 agonist | 0.029 0.009 DBMET00989 | DBMET00989 | |
| 0.057 | 0.173 | 0.09 | Carbonic anhydrase III inhibitor | 0.09 0.075 DBMET00888 0.086 0.081 DBMET00989 | DBMET00888 | |
| 0.063 | 0.18 | 0.102 | Microtubule formation inhibitor | 0.102 0.088 DBMET00990 | DBMET00990 | |
| 0.069 | 0.187 | 0.162 | Toll-Like receptor 2 antagonist | 0.109 0.091 DBMET00888 0.116 0.082 DBMET00989 0.162 0.045 DBMET00991 | DBMET00991 | |
| 0.088 | 0.208 | 0.135 | DNA methyltransferase I inhibitor | 0.135 0.122 DBMET00989 | DBMET00989 | |
| 0.037 | 0.159 | 0.059 | Adenine nucleotide translocase inhibitor | 0.059 0.031 DBMET00989 | DBMET00989 | |
| 0.159 | 0.284 | 0.336 | Antibacterial | 0.289 0.144 DBMET00988 0.336 0.11 DBMET00990 0.217 0.21 DBMET00989 0.272 0.157 DBMET00991 | DBMET00990 | |
| 0.14 | 0.267 | 0.192 | Antithrombotic | 0.192 0.188 DBMET00990 | DBMET00990 | |
| 0.02 | 0.198 | 0.062 | Dopamine agonist | 0.062 0.05 DBMET00989 | DBMET00989 | |
| 0.105 | 0.292 | 0.229 | 12-Lipoxygenase inhibitor | 0.229 0.123 DBMET00888 0.211 0.139 DBMET00989 | DBMET00888 | |
| 0.048 | 0.241 | 0.117 | Beta amyloid protein antagonist | 0.117 0.071 DBMET00888 | DBMET00888 | |
| 0.038 | 0.232 | 0.154 | ATPase (Vacuolar H+) inhibitor | 0.127 0.015 DBMET00988 0.154 0.007 DBMET00990 0.083 0.071 DBMET00989 | DBMET00990 | |
| 0.111 | 0.324 | 0.202 | Immunomodulator | 0.202 0.162 DBMET00988 | DBMET00988 | |
| 0.005 | 0.226 | 0.026 | Purinergic P2Y12 antagonist | 0.026 0.014 DBMET00888 | DBMET00888 | |
| 0.094 | 0.318 | 0.271 | Transcription factor NF kappa B inhibitor | 0.199 0.17 DBMET00989 0.271 0.113 DBMET00991 | DBMET00991 | |
| 0.061 | 0.288 | 0.358 | Amyloid beta precursor protein antagonist | 0.358 0.009 DBMET00888 | DBMET00888 | |
| 0.096 | 0.332 | 0.181 | Hypoxia-inducible factor 1 alpha inhibitor | 0.181 0.177 DBMET00990 | DBMET00990 | |
| 0.035 | 0.279 | 0.196 | Heme oxygenase stimulant | 0.196 0.002 DBMET00888 | DBMET00888 | |
| 0.041 | 0.289 | 0.122 | DNA polymerase I inhibitor | 0.122 0.067 DBMET00989 0.122 0.067 DBMET00992 | DBMET00992 | |
| 0.036 | 0.294 | 0.072 | Estrogen receptor alpha antagonist | 0.072 0.064 DBMET00888 0.071 0.066 DBMET00991 | DBMET00888 | |
| 0.076 | 0.342 | 0.113 | Papain-like protease (SARS coronavirus) inhibitor | 0.112 0.106 DBMET00989 0.113 0.101 DBMET00991 | DBMET00991 | |
| 0.056 | 0.384 | 0.139 | NOS3 expression enhancer | 0.139 0.085 DBMET00989 | DBMET00989 | |
| 0.076 | 0.405 | 0.138 | Death-associated protein kinase 2 inhibitor | 0.138 0.137 DBMET00888 0.138 0.136 DBMET00989 | DBMET00989 | |
| 0.023 | 0.369 | 0.1 | Topoisomerase II inhibitor | 0.1 0.086 DBMET00989 0.098 0.088 DBMET00991 | DBMET00989 | |
| 0.044 | 0.403 | 0.18 | Antiamyloidogenic | 0.18 0.114 DBMET00888 | DBMET00888 | |
| 0.102 | 0.469 | 0.199 | Interleukin 2 agonist | 0.199 0.192 DBMET00990 | DBMET00990 | |
| 0.012 | 0.404 | 0.035 | Elastase 3B inhibitor | 0.035 0.013 DBMET00992 | DBMET00992 | |
| 0.012 | 0.404 | 0.035 | Elastase 3A inhibitor | 0.035 0.013 DBMET00992 | DBMET00992 | |
| 0.012 | 0.404 | 0.035 | Elastase 2B inhibitor | 0.035 0.013 DBMET00992 | DBMET00992 | |
| 0.045 | 0.465 | 0.18 | Lipoxygenase inhibitor | 0.18 0.164 DBMET00888 | DBMET00888 | |
| 0.055 | 0.479 | 0.299 | 15-Lipoxygenase inhibitor | 0.299 0.133 DBMET00888 | DBMET00888 | |
| 0.013 | 0.454 | 0.143 | M17 leucyl aminopeptidase inhibitor | 0.143 0.06 DBMET00888 | DBMET00888 | |
| 0.007 | 0.448 | 0.064 | HIV-1 integrase (Strand Transfer) inhibitor | 0.059 0.042 DBMET00888 0.053 0.047 DBMET00989 0.064 0.039 DBMET00991 | DBMET00991 | |
| 0.077 | 0.52 | 0.398 | Caspase 3 stimulant | 0.226 0.136 DBMET00989 0.228 0.134 DBMET00992 0.398 0.045 DBMET00991 | DBMET00991 | |
| 0.007 | 0.456 | 0.076 | HIV-1 integrase (3'-Processing) inhibitor | 0.076 0.036 DBMET00888 0.072 0.038 DBMET00989 0.072 0.038 DBMET00991 | DBMET00888 | |
| 0.004 | 0.491 | 0.117 | Antineoplastic antibiotic | 0.078 0.058 DBMET00988 0.117 0.039 DBMET00990 | DBMET00990 | |
| 0.018 | 0.515 | 0.154 | Lipid peroxidase inhibitor | 0.154 0.066 DBMET00989 0.108 0.107 DBMET00991 | DBMET00989 | |
| 0.025 | 0.53 | 0.084 | Thioredoxin reductase inhibitor | 0.084 0.053 DBMET00988 | DBMET00988 | |
| 0.016 | 0.559 | 0.139 | Chelator | 0.139 0.04 DBMET00992 | DBMET00992 | |
| 0.02 | 0.565 | 0.289 | Free radical scavenger | 0.162 0.131 DBMET00888 0.289 0.055 DBMET00989 0.208 0.091 DBMET00991 | DBMET00989 | |
| 0.009 | 0.557 | 0.068 | HIV-1 integrase inhibitor | 0.068 0.052 DBMET00989 | DBMET00989 | |
| 0.079 | 0.635 | 0.2 | ErbB-1 antagonist | 0.2 0.089 DBMET00988 | DBMET00988 | |
| 0.005 | 0.598 | 0.092 | Phosphodiesterase 2A inhibitor | 0.092 0.01 DBMET00888 | DBMET00888 | |
| 0.02 | 0.627 | 0.255 | Antioxidant | 0.255 0.081 DBMET00989 0.246 0.086 DBMET00991 | DBMET00989 | |
| 0.004 | 0.612 | 0.101 | Phosphodiesterase II inhibitor | 0.101 0.011 DBMET00888 | DBMET00888 | |
| 0.028 | 0.636 | 0.237 | Interleukin 4 antagonist | 0.158 0.043 DBMET00990 0.237 0.015 DBMET00888 0.107 0.105 DBMET00989 | DBMET00888 | |
| 0.013 | 0.664 | 0.161 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.161 0.056 DBMET00888 | DBMET00888 | |
| 0.026 | 0.686 | 0.359 | Immunosuppressant | 0.359 0.082 DBMET00988 0.249 0.148 DBMET00990 | DBMET00988 | |
| 0.013 | 0.713 | 0.186 | Streptokinase A inhibitor | 0.186 0.142 DBMET00888 | DBMET00888 | |
| 0.023 | 0.727 | 0.091 | T cell inhibitor | 0.091 0.036 DBMET00988 0.086 0.046 DBMET00992 | DBMET00988 | |
| 0.006 | 0.721 | 0.072 | CDC25A inhibitor | 0.072 0.054 DBMET00992 | DBMET00992 | |
| 0.008 | 0.744 | 0.133 | Uric acid excretion stimulant | 0.133 0.031 DBMET00888 | DBMET00888 | |
| 0.006 | 0.762 | 0.037 | Estrogen-related receptor beta antagonist | 0.037 0.014 DBMET00888 | DBMET00888 | |
| 0.013 | 0.856 | 0.426 | Apoptosis agonist | 0.426 0.102 DBMET00988 0.313 0.163 DBMET00990 0.398 0.114 DBMET00991 | DBMET00988 | |
| 0.004 | 0.874 | 0.058 | Alpha tubulin antagonist | 0.058 0.032 DBMET00991 | DBMET00991 | |
| 0.003 | 0.885 | 0.047 | Catechol O-methyltransferase inhibitor | 0.032 0.023 DBMET00989 0.047 0.01 DBMET00991 | DBMET00991 | |
| 0.004 | 0.916 | 0.122 | Estrogen receptor beta antagonist | 0.122 0.03 DBMET00888 0.105 0.054 DBMET00991 | DBMET00888 | |
| 0.005 | 0.945 | 0.106 | Purinergic P2X2 antagonist | 0.106 0.027 DBMET00991 | DBMET00991 | |
| 0.006 | 0.946 | 0.096 | Glucose-6-phosphate translocase inhibitor | 0.096 0.007 DBMET00991 | DBMET00991 | |
| 0.004 | 0.962 | 0.13 | Estrogen antagonist | 0.13 0.038 DBMET00888 0.115 0.065 DBMET00991 | DBMET00888 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |